about
Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational StudyBolstering community cooperation in Ebola resurgence protocols: combining field blood draw and point-of-care diagnosisAfter Ebola in West Africa — Unpredictable Risks, Preventable EpidemicsBest practices to prevent transmission and control outbreaks of hand, foot, and mouth disease in childcare facilities: a systematic review.Ebola virus disease contact tracing activities, lessons learned and best practices during the Duport Road outbreak in Monrovia, Liberia, November 2015Achieving compliance with the International Health Regulations by overseas territories of the United Kingdom of Great Britain and Northern IrelandThe challenges of detecting and responding to a Lassa fever outbreak in an Ebola-affected setting.The health-related quality of life of children with hereditary retinal disorders and the psychosocial impact on their families.Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: Impact on outbreak response, case management and laboratory systems strengthening.Tracking and responding to an outbreak of tuberculosis using MIRU-VNTR genotyping and whole genome sequencing as epidemiological tools.Contact tracing performance during the Ebola epidemic in Liberia, 2014-2015Using evidence to inform response to the 2017 plague outbreak in Madagascar: a view from the WHO African Regional OfficeEbola Virus Infection Associated with Transmission from Survivors.Public health outcome of Tuberculosis Cluster Investigations, England 2010-2013Infectious disease outbreaks in the African region: overview of events reported to the World Health Organization in 2018Lessons learned from detecting and responding to recurrent measles outbreak in Liberia post Ebola-Epidemic 2016-2017Integrated disease surveillance and response implementation in Liberia, findings from a data quality audit, 2017A quantitative framework to define the end of an outbreak: application to Ebola Virus Disease
P50
Q28394360-EFBADDB3-C825-442D-92CA-9EE926E2B590Q28950587-B68E2B8B-44E2-465C-85BF-F8C90E43EE74Q29544577-8DADFC70-66ED-4269-B0AE-8314C77E7FA8Q30235238-094AE7F2-52E1-4C3C-862B-A283765A2DEEQ33797509-988AD662-5635-4FC9-8D72-4473654B8801Q34460434-2FD9CA0D-A095-4E91-8387-EC0E389C0542Q44106205-CDBEDCAA-40FA-4991-B35A-A10598F4B94EQ47268031-CD81BE88-F256-4CBA-8064-CAF06AE93BD3Q47557830-FFEE42AB-6BF3-4D19-9228-552BD3641950Q47626113-76364B29-05CC-4B08-8F9C-09EB2A49B118Q57091961-9C55AB84-4995-4A88-9AFD-5C598A2EEDF8Q57174530-2894F55F-6B21-4FFF-BD86-802DD4E468CDQ59541643-B17D9D1C-0B6B-43AA-A974-87804DDEB848Q91091355-741AC5AF-B449-44E9-A19B-64BAEA9B0CCEQ91223283-8E9311DC-CCE9-4280-803F-A6B1D3C3C621Q92557263-447A9E54-B094-49E3-85E6-7C8FC003ABA0Q92557274-1FBBB0A7-45F6-4033-B8CD-3121C399405DQ95605510-E283A7EE-8FE7-4D4D-9410-9A5FD2E167F7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Esther Hamblion
@ast
Esther Hamblion
@en
Esther Hamblion
@es
Esther Hamblion
@nl
Esther Hamblion
@sl
type
label
Esther Hamblion
@ast
Esther Hamblion
@en
Esther Hamblion
@es
Esther Hamblion
@nl
Esther Hamblion
@sl
prefLabel
Esther Hamblion
@ast
Esther Hamblion
@en
Esther Hamblion
@es
Esther Hamblion
@nl
Esther Hamblion
@sl
P106
P1153
35848676800
P21
P31
P496
0000-0003-4250-3696